Bruce C. Ritchie

Edmonton, AB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Title Not Found

Title Not Found

Journal: Arerugi = [Allergy]

Published: April 12, 2026

Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trial.

Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trial.

Journal: The Lancet. Haematology

Published: August 25, 2025

Disease control and disease activity in hereditary angioedema: two sides of the same coin?

Disease control and disease activity in hereditary angioedema: two sides of the same coin?

Journal: Frontiers in immunology

Published: May 19, 2025

Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment.

Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment.

Journal: Clinical reviews in allergy & immunology

Published: January 20, 2025

Feasibility and resource utilization of nurse-administered subcutaneous immunoglobulin therapy in antibody deficiency: A cross-sectional study.

Feasibility and resource utilization of nurse-administered subcutaneous immunoglobulin therapy in antibody deficiency: A cross-sectional study.

Journal: PloS one

Published: September 17, 2024

Antibody Responses in SARS-CoV-2-Exposed and/or Vaccinated Individuals Target Conserved Epitopes from Multiple CoV-2 Antigens.

Antibody Responses in SARS-CoV-2-Exposed and/or Vaccinated Individuals Target Conserved Epitopes from Multiple CoV-2 Antigens.

Journal: International journal of molecular sciences

Published: August 28, 2024

Centralized care model for hereditary angioedema overcomes geographical barriers.

Centralized care model for hereditary angioedema overcomes geographical barriers.

Journal: Frontiers in immunology

Published: April 07, 2024

Rationale and design of the multi organ inflammation with serial testing study: a comprehensive assessment of functional and structural abnormalities in patients with recovered COVID-19.

Rationale and design of the multi organ inflammation with serial testing study: a comprehensive assessment of functional and structural abnormalities in patients with recovered COVID-19.

Journal: Frontiers in medicine

Published: February 27, 2024

Biomarker risk assessment model identified high-risk patients with cancer who benefit from thromboprophylaxis.

Biomarker risk assessment model identified high-risk patients with cancer who benefit from thromboprophylaxis.

Journal: Annals of internal medicine

Published: February 05, 2024

Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study.

Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study.

Journal: The Lancet. Haematology

Published: January 09, 2024

Berotralstat in hereditary angioedema due to C1 inhibitor deficiency: first real-world evidence from a Canadian center.

Berotralstat in hereditary angioedema due to C1 inhibitor deficiency: first real-world evidence from a Canadian center.

Journal: Frontiers in immunology

Published: November 16, 2023

Title Not Found

Title Not Found

Journal: Arerugi = [Allergy]

Published: September 20, 2023

Showing 1-12 of 60

Last Updated: 09/26/2026